Purple Biotech (PPBT) Receivables (2019 - 2022)

Purple Biotech (PPBT) has 4 years of Receivables data on file, last reported at $431000.0 in Q4 2022.

• On a quarterly basis, Receivables changed N/A year-over-year to $431000.0 in Q4 2022; TTM through Dec 2022 was $431000.0, a N/A change from a year earlier, with the FY2022 full-year figure at $431000.0, changed N/A from the prior year.
• Receivables for Q4 2022 stood at $431000.0, down from $500000.0 in the prior quarter.
• Over the last five years, Receivables for PPBT reached as high as $1.5 million in Q4 2019 and fell as low as $431000.0 in Q4 2022.
• Historically, Receivables has averaged $703428.6 across 4 years, with a median of $500000.0 in 2020.
• Across the five-year window, Receivables tumbled 66.51% in 2020 and slumped 50.0% in 2021, its largest moves.
• Year by year, Receivables stood at $1.5 million in 2019, then tumbled by 66.51% to $500000.0 in 2020, then changed by 0.0% to $500000.0 in 2021, then dropped by 13.8% to $431000.0 in 2022.
• Per Business Quant data, the three most recent Receivables figures were $431000.0 in Q4 2022, $500000.0 in Q3 2021, and $500000.0 in Q2 2021.